pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer

Although a variety of drug delivery strategies have been designed for enhancing the treatment of Triple negative breast cancer (TNBC), combating with TNBCs is still dramatically challenged by the selection of appropriate therapeutic targets and insufficient tumor accumulation or inner penetration of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Xu, Liu, Chaoqian, Lin, Yinan, Fu, Jie, Lu, Guohong, Lu, Zhengmao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462792/
https://www.ncbi.nlm.nih.gov/pubmed/30957572
http://dx.doi.org/10.1080/10717544.2019.1576801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462792/
https://www.ncbi.nlm.nih.gov/pubmed/30957572
http://dx.doi.org/10.1080/10717544.2019.1576801

Ejemplares similares